1Heeringa J. Atrial fibrillation: is the prevalence rising? Eu- ropace,2010,12:451-452.
2Zhang S. Atrial fibrillation in China's Mainland: epidemiology and current management. Heart ,2009,95 : 1052-1055.
3Wolf PA,Abbott RD, Kannel WB, et al. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke, 1991, 22:983-988.
4Villani GQ, Piepoli PE, VilIaniPE, et al. Anticoagulationin atrial fibrillation; what is certain and what is to come. Eur Heart J, 2003, (Suppl) :45-50.
5Veinot JP, Harrity PJ, Gentile F, et al. Anatomy of the normal left atrial appendage: a quantitative study of age-related changes in 500 autopsy hearts;implications for echocardiographic examina- tion. Circulation, 1997,96 : 3112 -3115.
6Kamath S, Blann AD, Chin BS, et al. Platelet activation, haemo- rheology and thrombogenesis in acute atrialfibrillation: a compari- son with permanent atrial fibrillation, Heart, 2003,89: 1093- 1095.
7Agarwal S, Hachamovitch R, Menon V, et al. Current trial-asso- ciated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: A Meta-analysis. Arch Intern Med ,2012,172:623-631.
8Connolly S J, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarinpatients with atrial fibrillation. N Engl J Med, 2009, 361:1139-1151.
9Eikelboom JW, Wallentin L, Connolly S J, et al. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: An analysis of the ran- domized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation, 2011,123 : 2363-2372.
10Granger CB, Alexander JH, MeMurray JV, et al. For the ARIS- TOTLE committees and investigators apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med, 2011, 365 : 981- 992.
二级参考文献8
1[1]Wolf PA,Dawber TR,Thomas HE Jr,et al.Epidemiologic assessment of chronic atrial fibrillation and risk of stroke:the Framingham study.Neurology,1978,28(10):973-977.
2[2]Blackshear JL,Odell JA.Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation.Ann Thorac Surg,1996,61(2):755-759.
4[4]Lew SJ,Lim JK.Stroke prevention in elderly patients with atrial fibrillation.Singapore Med J,2002,43(4):198-201.
5[5]Madden J.Resection of the left auricular appendix.JAMA,1948,140(9):769-772.
6[6]Nakai T,Lesh MD,Gerstenfeld EP,et al.Percutaneous left atrial appendage transcatheter occlusion (PLAATO) for preventing cardioembolism first xxperience in canine model.Circulation,2002,105(18):2217-2222.
7[7]Sievert H,Lesh MD,Trepels T,et al.Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation:early clinical experience.Circulation,2002,105(16):1887-1889.
8[8]Ostermayer SH,Reisman M,Kramer PH,et al.Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation:results from the international multi-center feasibility trials.J Am Coll Cardiol,2005,46(1):9-14.
7Bucerius J,Gummert JF,Borger MA,et al.Stroke after cardiac surgery:a risk factor analysis of 16,184 consecutive adult patients[J].Ann Thorac Surg,2003,75 (2):472-478.
8Hogue CW Jr,Murphy SF,Schechtman KB,et al.Risk factors for early or delayed stroke after cardiac surgery[J].Circulation,1999,100(6):642-647.
9Dawson AG,Asopa S,Dunning J.Should patients undergoing cardiac surgery with atrial fibrillation have left atrial appendage exclusion.?[J].Interact Cardiovasc Thorac Surg,2010,10 (2):306-311.
10Maisel WH.Left atrial appendage occlusion--closure or just the beginning?[J].N Engl J Med,2009,360 (25):2601-2603.
